Events Search and Views Navigation
November 2018
MassBio Patient Advocacy Summit 2018
We are starting the Summit off with an inspiring keynote featuring Dr. Phil Reilly. He will be sharing his experiences as a highly respected clinical geneticist with an extensive track record of launching and building companies in the rare disease space.
This influential event is the go-to place to get inspired by the industry’s advocacy professionals, disease foundations, and patient organizations.
Find out more »15th Annual Pantheon 2018
Each year the California Life Sciences Association (CLSA), recognizes and honors excellence as it brings together California’s Life Sciences industry for one night at our Annual Pantheon DiNA Awards Ceremony. This evening serves as a celebration of the contributions and achievements of California’s leading life sciences innovators, a moment in time to pause and reflect on the industry’s legacy. You are cordially invited to join us on Friday, November 30th at the Westin St. Francis in San Francisco as we celebrate and recognize the impact that California’s therapeutic, diagnostic, medical device, and industrial biotechnology companies are making around the globe.
Find out more »December 2018
Healthcare Market Research
Great work in life science research does not always lead to better healthcare, often because of a lack of understanding the market. The quality of market research, similar to the quality of laboratory research, hinges on asking the best questions and carefully evaluating the answers.
Find out more »2018 MIT BioMAN Summit
The 2018 BioMAN Summit will bring together thought leaders from industry, academia, and government for a series of invited presentation and panel discussions that will:
• Identify where industry has made significant progress in developing enabling technologies for these products
• Investigate the most significant outstanding needs for process and analytical technologies to enable scaling of cell and gene therapy manufacturing operations
• Examine recent advances and outstanding needs in cell characterization technologies
• Learn about next-generation cell and gene therapy products and what new technologies will be required to bring them to patients
• Discuss opportunities for pre-competitive collaboration to facilitate advancement of biomanufacturing operations and ensure patient access to cell and gene therapy products